The Chief Executive Officer (CEO) of a pharmaceutical company suspects that one of the senior scientists in the company has been selling confidential information to a competitor. The CEO asks the scientist to take a polygraph test. In the context of the Employee Polygraph Protection Act, which of the following is true of the given scenario? A) The CEO can fire the scientist for refusing to take the polygraph test.
B) The scientist cannot refuse to take the polygraph test.
C) The scientist cannot be terminated for refusing to take the polygraph test.
D) The scientist can sue the firm for illegally attempting to conduct the polygraph test.

David burdick is the ceo of acme bubblegum, a successful public company. as one of the cofounders of the company, burdick has enjoyed speaking and writing about the success of acme bubblegum for several years. typically, he speaks at conferences or directly to the press, but recently, he has been blogging about his firm anonymously. specifically, he defended a recent advertising campaign that was unpopular among consumers and pointedly attacked one of acme bubblegum’s competitors. burdick deeply enjoys his anonymous blogging and believes that none of his readers actually know that he works for acme bubblegum.should burdick be allowed to praise his company’s performance anonymously online? should he be allowed to attack his competitors without disclosing his relationship with the company? how would you feel if the ceo of a company at which you shopped was secretly writing criticisms of his or her competition? how would you feel if you knew a writer for your favorite blog was actually closely involved in a company that the blog discussed? 1. define the ethical issue? 2. who are the primary stakeholders? 3. what are the possible alternatives? 4. how could you evaluate the ethical implications of the alternative actions (use appropriate decision rules)? 5. what action would you recommend and why?